以垂体瘤首诊的多发性内分泌腺瘤病1型4例报告并文献复习

张玉玲; 沈如飞; 吕扬帆; 李行; 周玲; 李蔚鑫; 隆敏

doi:10.16016/j.2097-0927.202110186

您当前的位置：

首页 >

文章列表页 >

以垂体瘤首诊的多发性内分泌腺瘤病1型4例报告并文献复习

临床医学 | 更新时间：2026-01-09

- 以垂体瘤首诊的多发性内分泌腺瘤病1型4例报告并文献复习
- Multiple endocrine adenomatosis type 1 with initial pituitary tumor: report of 4 cases and literature review
- 陆军军医大学学报 2022年44卷第10期页码：1061-1066
- 作者机构：
  
  1.400037 重庆，陆军军医大学(第三军医大学)第二附属医院内分泌科
  2.400037 重庆，陆军军医大学(第三军医大学)第二附属医院病理科
  3.210002 南京，南京大学医学院附属金陵医院内分泌科
- 作者简介：
  
  [隆敏，E-mail: Longmin_casper@163.comLONG Min, E-mail: Longmin_casper@163.com
- 基金信息：
  
  2018新桥医院临床科研项目“临床医学科研人才”(2018XLC3049);利益冲突声明所有作者声明不存在利益冲突。
- DOI：10.16016/j.2097-0927.202110186
  中图分类号： R730.4;R736;R736.4
- 收稿：2021-10-28，
  
  修回：2021-12-01，
  
  纸质出版：2022-05-30
- 稿件说明：
移动端阅览
张玉玲, 沈如飞, 吕扬帆, 等. 以垂体瘤首诊的多发性内分泌腺瘤病1型4例报告并文献复习[J]. 陆军军医大学学报, 2022,44(10):1061-1066.

Yuling ZHANG, Rufei SHEN, Yangfan LYU, et al. Multiple endocrine adenomatosis type 1 with initial pituitary tumor: report of 4 cases and literature review[J]. Journal of Army Medical University, 2022, 44(10): 1061-1066.
张玉玲, 沈如飞, 吕扬帆, 等. 以垂体瘤首诊的多发性内分泌腺瘤病1型4例报告并文献复习[J]. 陆军军医大学学报, 2022,44(10):1061-1066. DOI： 10.16016/j.2097-0927.202110186.

Yuling ZHANG, Rufei SHEN, Yangfan LYU, et al. Multiple endocrine adenomatosis type 1 with initial pituitary tumor: report of 4 cases and literature review[J]. Journal of Army Medical University, 2022, 44(10): 1061-1066. DOI： 10.16016/j.2097-0927.202110186.

摘要

目的

总结4例以垂体瘤首诊的多发性内分泌腺瘤病1型(multiple endocrine neoplasia type 1，MEN1)患者的临床特点及诊治过程。

方法

回顾性分析2016年10月至2020年12月因垂体瘤或垂体瘤术后至陆军军医大学第二附属医院就诊的4例MEN1患者的临床表现、生化指标、影像学资料、术后免疫组化染色及基因检测结果，并对相关文献进行复习。

结果

4例患者，其中男性1例，女性3例，年龄23~64岁。①3例为垂体大腺瘤(直径≥10 mm)，术后免疫组化染色证实生长激素(growth hormone，GH)+催乳素(prolactin，PRL)混合型瘤2例，GH瘤1例；1例为垂体微腺瘤(直径 < 10 mm)，临床诊断为无功能瘤；②4例患者均合并甲状旁腺功能亢进，其中1例合并胰腺神经内分泌肿瘤(G1期)，1例同时合并胰腺神经内分泌肿瘤(G1期)和双侧肾上腺占位，1例合并胰头占位；③2例患者接受全外显子测序，分别检测到c.249_252delGTCT和c.1277delG 2个MEN1基因杂合突变，后者为首次发现的基因突变位点。

结论

以垂体瘤首诊的MEN1患者，功能型大腺瘤多见，应常规完善相关内分泌激素、生化及影像学检查，并合理进行基因检测辅以多学科诊疗。

Abstract

Objective

To summarize the clinical characteristics of 4 patients with multiple endocrine neoplasia type 1 (MEN1) who were firstly diagnosed with pituitary adenomas.

Methods

Four patients with MEN1 admitted to our hospital from October 2016 to December 2020 due to pituitary tumor or after pituitary tumor surgery were subjected in this study. The clinical manifestations

biochemical indexes

imaging data

results of postoperative immunohistochemical staining and gene testing were collected and retrospectively analyzed. And relevant literature was reviewed as well.

Results

The 4 patients were 1 male and 3 females

and aged from 23 to 64 years. And among them

① 3 cases were macroadenomas (diameter ≥10 mm)

including 2 cases of growth hormone (GH)+prolactin (PRL) mixed tumors and 1 case of GH tumor after confirmed by immunohistochemical staining; the other 1 case was microadenoma (diameter < 10 mm)

and clinically diagnosed with nonfunctional tumor. ②All patients were complicated with hyperparathyroidism (PTH). In addition

1 case also had pancreatic neuroendocrine tumor (G1)

1 had both G1 and bilateral adrenal masses

and another 1 with pancreatic head mass. ③Two patients underwent whole exon sequencing

and 2 heterozygous mutations of MEN1 gene were detected: c.249_252delGTCT and c.1277delG

with the latter one being firstly reported.

Conclusion

In MEN1 patients with initial pituitary tumor

functioning macroadenomas is common

should receive routine endocrine hormone. And suspected patients biochemical and imaging examinations

as well as reasonable gene detection and supplemented multidisciplinary diagnosis and treatment

which are helpful to early detection and treatment of the disease.

关键词

Keywords

references

母义明. 垂体瘤诊治进展[J]. 解放军医学杂志, 2017, 42(7): 576-582.

MU Y M. Pituitary adenomas: an overview of clinical features, diagnosis and treatment[J]. Med J Chin PLA, 2017, 42(7): 576-582.

MOLITCH M E. Diagnosis and treatment of pituitary adenomas: a review[J]. JAMA, 2017, 317(5): 516-524. DOI: 10.1001/jama.2016.19699.

LOPES M B S. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary[J]. Acta Neuropathol, 2017, 134(4): 521-535. DOI: 10.1007/s00401-017-1769-8.

KAMILARIS C D C, STRATAKIS C A. Multiple endocrine neoplasia type 1 (MEN 1 ): an update and the significance of early genetic and clinical diagnosis[J ] . Front Endocrinol (Lausanne), 2019, 10: 339. DOI: 10.3389/fendo.2019.00339.

AL-SALAMEH A, CADIOT G, CALENDER A, et al . Clinical aspects of multiple endocrine neoplasia type 1[J ] . Nat Rev Endocrinol, 2021, 17(4): 207-224. DOI: 10.1038/s41574-021-00468-3.

MARQUES N V, KASUKI L, COELHO M C, et al . Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic[J ] . J Endocrinol Invest, 2017, 40(12): 1381-1387. DOI: 10.1007/s40618-017-0725-8.

VERGÈS B, BOUREILLE F, GOUDET P, et al . Pituitary disease in MEN type 1 (MEN 1 ): data from the France-Belgium MEN 1 multicenter study[J ] . J Clin Endocrinol Metab, 2002, 87(2): 457-465. DOI: 10.1210/jcem.87.2.8145..

ROGOZIŃSKI D, GILIS-JANUSZEWSKA A, SKALNIAK A, et al . Pituitary tumours in MEN 1 syndrome—the new insight into the diagnosis and treatment[J ] . Endokrynol Pol, 2019, 70(5): 445-452. DOI: 10.5603/EP.a2019.0026..

THAKKER R V, NEWEY P J, WALLS G V, et al . Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN 1 )[J ] . J Clin Endocrinol Metab, 2012, 97(9): 2990-3011. DOI: 10.1210/jc.2012-1230..

中华医学会神经外科学分会、中国垂体腺瘤协作组、中华医学会内分泌学分会. 中国肢端肥大症诊治指南(2013版)[J]. 中华医学杂志, 2013, 93(27): 2106-2111. DOI: 10.3760/cma.j.issn.0376-2491.2013.27.005.

Neurosurgery Branch of Chinese Medical Association, China Pituitary Adenoma Collaborative Group, Endocrinology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of acromegaly (2013 editon)[J]. Nat Med J China, 2013, 93(27): 2106-2111. DOI: 10.3760/cma.j.issn.0376-2491.2013.27.005.

HU W M, ZHANG Q, HUANG L H, et al . Identification of novel variants in MEN1: a study conducted with four mul-tiple endocrine neoplasia type 1 patients[J ] . Horm Metab Res, 2020, 52(11): 788-795. DOI: 10.1055/a-1147-1375.

FROST M, LINES K E, THAKKER R V. Current and emerging therapies for PNETs in patients with or without MEN 1 [J ] . Nat Rev Endocrinol, 2018, 14(4): 216-227. DOI: 10.1038/nrendo.2018.3.

DREIJERINK K M, GOUDET P, BURGESS J R, et al . Breast-cancer predisposition in multiple endocrine neoplasia type 1[J ] . N Engl J Med, 2014, 371(6): 583-584. DOI: 10.1056/NEJMc1406028.

LLOYD R V, JIN L, FIELDS K, et al . Effects of estrogens on pituitary cell and pituitary tumor growth[J ] . Pathol Res Pract, 1991, 187(5): 584-586. DOI: 10.1016/s0344-0338(11)80150-0.

VANNUCCI L, MARINI F, GIUSTI F, et al . MEN 1 in children and adolescents: data from patients of a regional referral center for hereditary endocrine tumors[J ] . Endocrine, 2018, 59(2): 438-448. DOI: 10.1007/s12020-017-1322-5..

TROUILLAS J, LABAT-MOLEUR F, STURM N, et al . Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN 1 ): a case-control study in a series of 77 patients versus 2509 non-MEN 1 patients[J ] . Am J Surg Pathol, 2008, 32(4): 534-543. DOI: 10.1097/pas.0b013e31815ade45..

DE LAAT J M, VAN LEEUWAARDE R S, VALK G D. The importance of an early and accurate MEN 1 diagnosis[J ] . Front Endocrinol (Lausanne), 2018, 9: 533. DOI: 10.3389/fendo.2018.00533.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据